Latest filings (excl ownership)
S-3/A
Shelf registration (amended)
30 Apr 24
S-3
Shelf registration
23 Apr 24
8-K
Other Events
27 Mar 24
8-K
LIXTE Provides Update on Progress with LB-100 as a PP2A Inhibitor to Enhance Chemotherapy and Immunotherapy Cancer Treatments
22 Mar 24
10-K
2023 FY
Annual report
19 Mar 24
8-K
Professor René Bernards to Present New Pre-Clinical Data
27 Feb 24
8-K
LIXTE Biotechnology Enters into Exclusive Immune Oncology Patent License Agreement with NINDS and NCI
26 Feb 24
8-K
Other Events
30 Jan 24
8-K
Departure of Directors or Certain Officers
28 Nov 23
8-K
LIXTE Biotechnology Provides Update on Clinical Progress and Expanding Collaborations
13 Nov 23
10-Q
2023 Q3
Quarterly report
9 Nov 23
8-K
Entry into a Material Definitive Agreement
17 Oct 23
DEFA14A
Additional proxy soliciting materials
10 Oct 23
DEF 14A
Definitive proxy
10 Oct 23
8-K
Termination of a Material Definitive Agreement
4 Oct 23
PRE 14A
Preliminary proxy
29 Sep 23
8-K
LIXTE Appoints Bas van der Baan as President and Chief Executive Officer
27 Sep 23
8-K
Other Events
20 Sep 23
EFFECT
Notice of effectiveness
22 Aug 23
CORRESP
Correspondence with SEC
18 Aug 23
UPLOAD
Letter from SEC
15 Aug 23
S-3
Shelf registration
11 Aug 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
D
$3.50 mm in options, sold $3.50 mm, 1 investor
1 Aug 23
8-K
Other Events
21 Jul 23
424B5
Prospectus supplement for primary offering
20 Jul 23
8-K
Entry into a Material Definitive Agreement
20 Jul 23
8-K
Other Events
26 Jun 23
8-K
Amendments to Articles of Incorporation or Bylaws
5 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
30 May 23
10-Q
2023 Q1
Quarterly report
10 May 23
424B5
Prospectus supplement for primary offering
9 May 23
8-K
Termination of a Material Definitive Agreement
9 May 23
8-K
Other Events
25 Apr 23
DEF 14A
Definitive proxy
11 Apr 23
8-K
Other Events
5 Apr 23
10-K
2022 FY
Annual report
29 Mar 23
PRE 14A
Preliminary proxy
24 Mar 23
8-K
Lixte Biotechnology Holdings Reports Newly Published Independent Pre-clinical Research
15 Feb 23
8-K
Other Events
9 Feb 23
Latest ownership filings
4
der Baan Bastiaan Jeroen van
16 Oct 23
4/A
Rene Bernards
5 Oct 23
4
der Baan Bastiaan Jeroen van
5 Oct 23
4
Rene Bernards
4 Oct 23
4
der Baan Bastiaan Jeroen van
27 Sep 23
4
der Baan Bastiaan Jeroen van
7 Jul 23
4
Yun Yen
7 Jul 23
4
Regina Brown
7 Jul 23
4
Stephen J. Forman
7 Jul 23
4/A
der Baan Bastiaan Jeroen van
5 Jan 23
4
der Baan Bastiaan Jeroen van
4 Jan 23
4
Rene Bernards
16 Dec 22
4
ERIC FORMAN
13 Dec 22
4
Rene Bernards
13 Dec 22
4
ERIC FORMAN
23 Nov 22
4
Regina Brown
22 Nov 22
4
James Miser
21 Nov 22
3
James Miser
21 Nov 22
4
ERIC FORMAN
21 Nov 22
4
Rene Bernards
15 Nov 22
4
ROBERT N WEINGARTEN
9 Nov 22
4
ERIC FORMAN
9 Nov 22
4
John S Kovach
9 Nov 22
4
Yun Yen
3 Aug 22
4
Philip F Palmedo
3 Aug 22
4
Stephen J. Forman
3 Aug 22
4
Regina Brown
3 Aug 22
3
Rene Bernards
28 Jul 22
4
der Baan Bastiaan Jeroen van
18 Jul 22
3
der Baan Bastiaan Jeroen van
18 Jul 22
SC 13G/A
FORMAN ERIC
6 Apr 22
SC 13G
KRINSKY GLENN
6 Apr 22
4
ERIC FORMAN
6 Apr 22
3
GLENN KRINSKY
6 Apr 22
5
Gil Schwartzberg
14 Feb 22
SC 13G/A
SABBY MANAGEMENT, LLC
4 Jan 22
4
Stephen J. Forman
2 Jul 21
4
Yun Yen
2 Jul 21
4
Gil Schwartzberg
2 Jul 21
4
Philip F Palmedo
2 Jul 21